...
首页> 外文期刊>Research journal of pharmacy and technology >Evaluation of Covariates using Population Pharmacokinetics approach for dose Individualization of Levothyroxine in Patients with Post Thyroidectomy and 131I ablation Therapy
【24h】

Evaluation of Covariates using Population Pharmacokinetics approach for dose Individualization of Levothyroxine in Patients with Post Thyroidectomy and 131I ablation Therapy

机译:利用甲状腺切除术患者左甲醛剂量胞质剂量的可协变量评价及131I烧蚀治疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The current therapy for patients with thyroid cancer is total or near to total thyroidectomy with Radio Iodine treatment. Subsequent to the thyroidectomy the patients are on Levothyroxine as a supplement therapy to maintain the Thyroid hormone levels.Levothyroxine has been considered as a narrow therapeutic index drug. In Thyroid cancer patients, radio-iodine ablation procedure causes hypothyroid state which will be further elongated by the administration of sub optimal doses and hyperthyroid symptoms with higher doses. The current study was conducted to evaluate the covariates influencing the drug concentration of levothyroxine in our target population, i.e Patient with Papillary carcinoma, undergone total thyroidectomy followed by I3II ablation and on Levothyroxine.
机译:目前对甲状腺癌患者的治疗总量或附近的甲状腺切除术与无线电碘治疗。 在甲状腺切除术后,患者在左旋甲磺酮上作为补充疗法,以维持甲状腺激素水平。已经认为甲状腺激素水平。已经被认为是狭窄的治疗指数药物。 在甲状腺癌患者中,放射性碘消融程序导致甲状腺功能亢进状态,其将通过亚最佳剂量的给药和甲状腺素症状具有更高剂量的甲状腺症状进一步伸长。 进行目前的研究以评估影响我们靶名群体中左羟基嗪的药物浓度的协变量,即患有乳头状癌的患者,经历了总甲状腺切除术,然后是I3II消融和左甲苯胺。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号